Changing Course: Reversing Direct Oral Anticoagulants in the Emergency Department
The development of direct oral anticoagulants (DOACs) has advanced the therapeutic landscape for the management of thromboembolic events. Specific agents that rapidly reverse the effects of DOACs are now available and offer safe and effective options for patients who experience an emergency DOAC-associated bleeding event.
This ACEP Chapter Educational Lecture Series offers clinical pearls for the assessment of bleeding severity in patients receiving DOACs; expert-guided insights to rapid reversal of urgent DOAC-associated bleeding; and clinical decision support tools to optimize outcomes in patients requiring reversal of DOACs.
Locations:
Oregon
Connecticut
South Carolina
Georgia
Michigan
Rhode Island
Missouri
Maryland
Illinois
Arizona
Front Lines of Family Medicine: Management and Prevention of Influenza in High-Risk Patients
Are you prepared to manage patients with influenza this season? Family physicians are a vital line of defense against morbidity and mortality from influenza, especially for populations at high risk of complications. This educational activity will address strengthening your recommendation for the influenza vaccine, identifying high-risk patients, and evaluating the safety and efficacy of available antivirals. With access to up-to-date information, family medicine physicians will be better able to care for patients with influenza and successfully navigate challenges encountered in practice.
Locations:
Phoenix, AZ
Hilton Head, SC
Deadwood, SD
Wintergreen, VA
Dublin, OH
Girdwood, AK
Boca Raton, FL
Jackson, MS
Miramar Beach,FL
Hurstborne, KY
Virtual – NJ, AL, MO, OK, CA
Influenza Updates Diagnosis, Management, and Prevention in the Emergency Department
How effectively are you managing influenza in your emergency department? This educational activity offers pearls for caring for patients with influenza in the emergency department this flu season, including identifying patients at high risk of complications, recognizing patients who should receive antivirals for prophylaxis or treatment, and reviewing efficacy and safety of available antivirals. With access to up-to-date information, emergency physicians will be better able to care for patients with influenza and successfully navigate challenges encountered in practice.
Locations:
Florida
California
Georgia
Rhode Island
Oregon
Neurogenic orthostatic hypotension (nOH) is a subset of orthostatic hypotension, which stems from an impairment of the autonomic nervous system and is commonly seen in patients with Parkinson’s disease, diabetes, and other disorders. In affected patients, nOH may contribute to falls and the concomitant sequelae related to falls, such as fractures, head trauma, limitations to daily activities, decreased independence, and diminished health-related quality of life.
In this one-hour, grass roots grand rounds activity, expert faculty will review the management of nOH and outline strategies to screen, assess, and intervene in hospital-based cases of nOH for prevention of falls.
Locations:
Corinth, MS
Teaneck NJ
Hilo, HI
Johnstown, PA
Practical Approaches for MS Infusion Therapies
Are you up to date with the most current clinical information and real-world data regarding infusion therapy for multiple sclerosis (MS)? This educational activity provides comprehensive guidance on the important clinical steps to be undertaken before, during, and after administration of infusion therapies. Two real-world patient scenarios offer attendees the opportunity to consider best practices, share potential approaches and solutions to the case challenges, as well as have their questions regarding infusion therapies answered.
Location:
Atlanta, GA
Denver, CO
Phoenix, AZ
Reducing CV Risk in Patients With T2D: A Call to Action
All of the major risk factors for heart disease are associated with type 2 diabetes (T2D), and family physicians at the front line of care need to consider treatments that will not only help patients reach glycemic goals, but also reduce the risk of cardiovascular (CV) disease.
In this one-hour educational activity, learn how to utilize guideline recommendations for treatment selection to reduce CV risk in patients with T2D, evaluate the results of CV outcomes trials for the multitude of available treatment options, and improve adherence to lifestyle changes and pharmacologic therapies in patients with T2D.
Locations:
Virtual, GA
Miramar Beach, FL
Portland, ME
Austin, TX
Asheville, NC
The landscape of maintenance treatment options for ovarian cancer has been rapidly expanding and continues to evolve as new data emerge. Maintenance therapy with poly(ADP-ribose)
polymerase (PARP) inhibitors and bevacizumab has demonstrated improvements in progression-free survival. A recent trial showed that maintenance therapy involving a PARP inhibitor improved overall survival in patients with platinum-sensitive recurrent ovarian cancer associated with BRCA1/2 mutations.
In this virtual/live grand rounds activity, an expert will examine relevant advances in genetic biomarker testing to individualize therapy, assess recent efficacy and safety data related to PARP inhibitors and bevacizumab maintenance therapy, and review strategies to effectively prevent and manage adverse effects.
Locations:
Quincy, IL
Corinth, MS
Victoria TX